Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
BMC Cancer
|
December 22, 2010
The colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information
Wendy L Allen, Puthen V Jithesh, Gavin R Oliver, et al.
The FEBS Journal
|
March 4, 2021
Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer
Christopher McCann, Anna Matveeva, Katherine McAllister, et al.
Cell Death and Differentiation
|
March 4, 2018
Simulating and predicting cellular and in vivo responses of colon cancer to combined treatment with chemotherapy and IAP antagonist Birinapant/TL32711
Nyree Crawford, Manuela Salvucci, Christian T Hellwig, et al.
Molecular Cancer Therapeutics
|
January 24, 2007
The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells
Wendy L Allen, Estelle G McLean, John Boyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2015
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL
Robbie Carson, Basak Celtikci, Cathy Fenning, et al.
Cancer Research
|
August 9, 2003
Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling
Pamela J Maxwell, Daniel B Longley, Tariq Latif, et al.
Plos One
|
January 10, 2013
Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression
Dario Barbone, Priscilla Cheung, Sailaja Battula, et al.
Molecular Cancer Therapeutics
|
June 6, 2012
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells
Wendy L Allen, Richard C Turkington, Leanne Stevenson, et al.
Oncotarget
|
May 7, 2016
Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
Philip D Dunne, Paul G O'Reilly, Helen G Coleman, et al.
Cancer Research
|
May 1, 2002
The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates
Daniel B Longley, John Boyer, Wendy L Allen, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
BMC Cancer
|
December 22, 2010
The colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information
Wendy L Allen, Puthen V Jithesh, Gavin R Oliver, et al.
The FEBS Journal
|
March 4, 2021
Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer
Christopher McCann, Anna Matveeva, Katherine McAllister, et al.
Cell Death and Differentiation
|
March 4, 2018
Simulating and predicting cellular and in vivo responses of colon cancer to combined treatment with chemotherapy and IAP antagonist Birinapant/TL32711
Nyree Crawford, Manuela Salvucci, Christian T Hellwig, et al.
Molecular Cancer Therapeutics
|
January 24, 2007
The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells
Wendy L Allen, Estelle G McLean, John Boyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2015
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL
Robbie Carson, Basak Celtikci, Cathy Fenning, et al.
Cancer Research
|
August 9, 2003
Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling
Pamela J Maxwell, Daniel B Longley, Tariq Latif, et al.
Plos One
|
January 10, 2013
Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression
Dario Barbone, Priscilla Cheung, Sailaja Battula, et al.
Molecular Cancer Therapeutics
|
June 6, 2012
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells
Wendy L Allen, Richard C Turkington, Leanne Stevenson, et al.
Oncotarget
|
May 7, 2016
Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
Philip D Dunne, Paul G O'Reilly, Helen G Coleman, et al.
Cancer Research
|
May 1, 2002
The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates
Daniel B Longley, John Boyer, Wendy L Allen, et al.
Page
of 12